ST4206 is an Orally Active Adenosine A2A Antagonist
More and more evidence suggesting that the adenosine A2A receptor is a promising target for antiparkinson treatment. Adenosine A2A receptors always locate within the caudate-putamen, nucleus accumbens, and olfactory tubercle.…